Super Lysine Plus
NDC 70084-420
Product Information
Super Lysine Plus is a OTC MONOGRAPH FINAL-approved product labeled by Quantum, Inc.. This product is primarily utilized in pharmaceutical processing or compounding. It is supplied as a green product. This product entry covers the primary NDC 70084-420 and 2 associated package configurations. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Labeler & Regulatory Data
Marketing Timeline
Product Characteristics
Code Structure Chart
Product Details
What is NDC 70084-420?
What are the uses of this product?
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- MENTHOL, UNSPECIFIED FORM (UNII: L7T10EIP3A)
- MENTHOL, UNSPECIFIED FORM (UNII: L7T10EIP3A) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- CALENDULA OFFICINALIS FLOWER (UNII: P0M7O4Y7YD)
- ECHINACEA PURPUREA (UNII: QI7G114Y98)
- BENZOIN RESIN (UNII: GK21SBA74R)
- HONEY (UNII: Y9H1V576FH)
- GOLDENSEAL (UNII: ZW3Z11D0JV)
- LYSINE HYDROCHLORIDE (UNII: JNJ23Q2COM)
- TEA TREE OIL (UNII: VIF565UC2G)
- MELALEUCA CAJUPUTI LEAF OIL (UNII: 5O59RMR6DU)
- OLIVE OIL (UNII: 6UYK2W1W1E)
- PROPOLIS WAX (UNII: 6Y8XYV2NOF)
- VITAMIN A PALMITATE (UNII: 1D1K0N0VVC)
- CHOLECALCIFEROL (UNII: 1C6V77QF41)
- .ALPHA.-TOCOPHEROL (UNII: H4N855PNZ1)
- ZINC OXIDE (UNII: SOI2LOH54Z)
- YELLOW WAX (UNII: 2ZA36H0S2V)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 1812680 - menthol 0.1 % Topical Ointment
- RxCUI: 1812680 - menthol 0.001 MG/MG Topical Ointment
- RxCUI: 1812685 - Lysine Plus 0.1 % Topical Ointment
- RxCUI: 1812685 - menthol 0.001 MG/MG Topical Ointment [Lysine Plus]
* Please review the full disclaimer at the bottom of this page.